GENSCRIPT BIO
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-16
Analyst
HSBC
Equibles does not estimate personal net worth.
Linda Xu is recorded as Analyst at HSBC. Linda Xu has spoken on 1 earnings call across 1 company, most recently for GENSCRIPT BIO on March 16, 2026. The companies whose calls Linda Xu spoke on are classified in the Healthcare sector.
“One is to follow up the questions from Dr. Huang, and we know that life sciences business has achieved solid growth last year, and also with a slight decrease in the GDP margin.”
HSBC
Analyst
Transcript header (unverified)
GENSCRIPT BIO
Biotechnology · Healthcare
2025 Annual Results Conference
GENSCRIPT BIO